lupus nephritisSLEsystemic lupus erythematosusAPSdiabetesprednisoneAmsterdam Lupus Cohort
…ersistent burden of CVRFs, particularly in patients with APS or lupus nephritis. Significant improvements in physical activity and blood pressu…
390articles mentioning diseases
481disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: systemic lupus erythematosus ×
systemic lupus erythematosus
This disease is selected. Its supporting articles are shown below.
Articles mentioning systemic lupus erythematosus
390 articles · page 23 of 33Systemic Lupus ErythematosusSLEAutoimmune Haemolytic Anaemiamycophenolate mofetilRituximabhydroxychloroquinePrednisolonePubMedCovidence.org
…mia (AIHA) represents a serious haematological manifestation of Systemic Lupus Erythematosus (SLE). Reported prevalence estimates vary widely across studies…
89.3%
lupus nephritisSLESLE-PAHsystemic lupus erythematosusSLE-APSpregnancy
…able for treating active systemic lupus erythematosus (SLE) and lupus nephritis (LN). However, GC can cause significant comorbidities and irrev…
systemic lupus erythematosusSLEHydroxychloroquineHCQUniversity Hospital of PaduaRheumatology Unit
…s Hydroxychloroquine (HCQ) is recommended for the management of systemic lupus erythematosus (SLE). However, substantial interindividual pharmacokinetic var…
Systemic lupus erythematosusSLEhydroxychloroquineAzathioprineMethotrexatebelimumabanifrolumabprednisone
…Objectives Background Systemic lupus erythematosus (SLE) is a chronic, heterogeneous autoimmune disease requiring …
Systemic lupus erythematosusSLEBMS-986353CD19-directed CAR T cell therapyglucocorticoids
…Objectives Systemic lupus erythematosus (SLE) is characterized by aberrant B-cell activity and systemic…
systemic lupus erythematosusSLEianalumabSRI-6NCT03656562SRI-4
…xpand upon previously published Phase 2 results of ianalumab in systemic lupus erythematosus (SLE) by adding post-end-of-treatment (EoT) data until end-of-s…
systemic lupus erythematosusSLEanifrolumabanifrolumabAbstractrituximabbelimumabprednisolone
…, and steroid-sparing potential of anifrolumab in patients with systemic lupus erythematosus (SLE) treated at a tertiary referral center in Denmark.Methods …
SLEsystemic lupus erythematosusSLE-DASSLEDASCOVID-19herpes zosterAnifrolumabSpanish rheumatology centers
…1° In real-life clinical setting, anifrolumab improved multiple SLE activity measures at 3 and 6 months, with a substantial proport…
Systemic lupus erythematosusSLE-DASSLE-associated HUVShypocomplementemic urticarial vasculitis syndromeanifrolumabprednisone
…Objectives Systemic lupus erythematosus (SLE) and hypocomplementemic urticarial vasculitis syndrome (HU…
systemic lupus erythematosusSLEIRF5 inhibitors
…fferentiation downstream of TLR7/8/9 signaling, contributing to systemic lupus erythematosus (SLE) pathogenesis. Despite its genetic and pre-clinical valida…
systemic lupus erythematosusSLEanifrolumab
…treatment responses, and safety of anifrolumab in patients with systemic lupus erythematosus (SLE).Methods We are reporting the clinical profiles, treatment…